Q4 2019 Eton Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, and welcome to the Eton Pharmaceuticals Fourth Quarter 2019 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
At this time, I would like to turn it over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals. Please proceed.
Thank you, operator. Good afternoon, everyone, and welcome to Eton's Fourth Quarter 2019 Conference Call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, eatonpharma.com. Joining me on our call today are Sean Brynjelsen, our CEO; and Wilson Troutman, our CFO.
Before we begin, I would like to remind everyone that statements made during this call may contain forward-looking statements and involve risks and uncertainties that could cause actual results to differ materially from those contained in these forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |